Jotwani Vasantha, Scherzer Rebecca, Estrella Michelle M, Jacobson Lisa P, Witt Mallory D, Palella Frank, Ho Ken, Bennett Michael, Parikh Chirag R, Ix Joachim H, Shlipak Michael
Department of Medicine, San Francisco VA Medical Center, San Francisco, CA, USA.
Kidney Health Research Collaborative, San Francisco VA Medical Center and University of California, San Francisco, CA, USA.
Antivir Ther. 2017;22(5):421-429. doi: 10.3851/IMP3124. Epub 2017 Jan 5.
Chronic kidney disease (CKD) is common among HIV-infected individuals but serum creatinine is insensitive for detecting kidney damage at early stages. We hypothesized that HIV infection would be associated with elevations in subclinical markers of kidney injury and fibrosis in a contemporary cohort of men.
In this cross-sectional study, we measured urine levels of interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), pro-collagen type III N-terminal pro-peptide (PIIINP) and albumin-creatinine ratio (ACR) in 813 HIV-infected and 331 uninfected men enrolled in the Multicenter AIDS Cohort Study.
Median eGFR was 95 ml/min/1.73 m among African-Americans (n=376) and 87 ml/min/1.73 m among Caucasians (n=768). Among HIV-infected men, the median CD4 lymphocyte count was 572 cells/mm and 76% of men had undetectable HIV RNA levels. After multivariable adjustment for traditional CKD risk factors including eGFR, HIV infection was associated with 52% higher urine IL-18 (95% CI, 33%, 73%), 44% higher KIM-1 (27%, 64%), 30% higher PIIINP (15%, 47%) and 84% higher ACR (54%, 120%), with similar effect sizes among African-Americans and Caucasians (P>0.2 for tests of interaction by race). These associations remained statistically significant in analyses that excluded persons with detectable HIV RNA levels and in models that adjusted for cumulative exposure to tenofovir disoproxil fumarate.
Compared with uninfected men, HIV-infected men had more extensive glomerular and tubulointerstitial damage, as assessed by urine biomarkers. Future studies should evaluate whether combinations of biomarkers can be used to monitor stages of kidney injury and to predict CKD risk in HIV-infected individuals.
慢性肾脏病(CKD)在HIV感染者中很常见,但血清肌酐在早期检测肾脏损伤方面不敏感。我们假设在当代男性队列中,HIV感染会与肾脏损伤和纤维化的亚临床标志物升高有关。
在这项横断面研究中,我们测量了参与多中心艾滋病队列研究的813名HIV感染者和331名未感染者的尿液中白细胞介素-18(IL-18)、肾脏损伤分子-1(KIM-1)、III型前胶原N端前肽(PIIINP)和白蛋白肌酐比值(ACR)的水平。
非裔美国人(n = 376)的估算肾小球滤过率(eGFR)中位数为95 ml/min/1.73 m²,白种人(n = 768)为87 ml/min/1.73 m²。在HIV感染者中,CD4淋巴细胞计数中位数为572个细胞/mm³,76%的男性HIV RNA水平检测不到。在对包括eGFR在内的传统CKD危险因素进行多变量调整后,HIV感染与尿液IL-18升高52%(95%CI,33%,73%)、KIM-1升高44%(27%,64%)、PIIINP升高30%(15%,47%)和ACR升高84%(54%,120%)相关,非裔美国人和白种人的效应大小相似(种族交互作用检验P>0.2)。在排除HIV RNA水平可检测到的人群的分析以及调整了富马酸替诺福韦二吡呋酯累积暴露量的模型中,这些关联仍具有统计学意义。
与未感染男性相比,通过尿液生物标志物评估,HIV感染男性存在更广泛的肾小球和肾小管间质损伤。未来的研究应评估生物标志物组合是否可用于监测HIV感染者的肾脏损伤阶段并预测CKD风险。